<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Genmab — December 2011]]></title><description><![CDATA[<p dir="auto">Så er vi oppe på 71 ofatumumab forsøg.  2nye idag! Har dog mistet overblikket over hvilke der er nye <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f435.png?v=de222e39001" class="not-responsive emoji emoji-android emoji--monkey_face" style="height:23px;width:auto;vertical-align:middle" title=":o)" alt="🐵" /></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/451441/genmab-december-2011</link><generator>RSS for Node</generator><lastBuildDate>Sat, 20 Jun 2026 00:51:29 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/451441.rss" rel="self" type="application/rss+xml"/><pubDate>Thu, 22 Dec 2011 15:38:11 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to Genmab — December 2011 on Fri, 23 Dec 2011 12:07:20 GMT]]></title><description><![CDATA[<p dir="auto">De 9 af studierne er enten completed eller withdrawn, så der køre 62 aktive studier.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10067307</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10067307</guid><dc:creator><![CDATA[MadsSkjern]]></dc:creator><pubDate>Fri, 23 Dec 2011 12:07:20 GMT</pubDate></item></channel></rss>